Treatment of Chronic Lymphocytic Leukemia
Jan A. Burger
Abstract
Treatment of CLL, the most common leukemia in the West, has undergone a revolution in the past few years with the development of agents that target signaling kinases and cell-survival mediators. Survival even among patients with a poor prognosis now exceeds 8 years.
Topics & Concepts
MedicineChronic lymphocytic leukemiaLeukemiaOncologyImmunologyInternal medicineCancer researchChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Myeloid Leukemia Treatments